Tryptophan and Kynurenine Levels and Its Association With Sleep, Nonphysical Fatigue, and Depression in Chronic Hemodialysis Patients

2006 Phillipson, 1993, Sleep apnea–a major public health problem, N Engl J Med, 328, 1271, 10.1056/NEJM199304293281712 Shepard, 1992, Hypertension, cardiac arrhythmias, myocardial infarction, and stroke in relation to obstructive sleep apnea, Clin Chest Med, 13, 437, 10.1016/S0272-5231(21)00873-X De Santo, 2010, Sleep disorders in kidney disease, Minerva Urol Nefrol, 62, 111 Perl, 2006, Sleep disorders in end-stage renal disease: ‘Markers of inadequate dialysis’?, Kidney Int, 70, 1687, 10.1038/sj.ki.5001791 Gusbeth-Tatomir, 2007, Sleep disorders: a systematic review of an emerging major clinical issue in renal patients, Int Urol Nephrol, 39, 1217, 10.1007/s11255-007-9262-2 Merlino, 2008, Sleep disturbances in dialysis patients, J Nephrol, 21, S66 Bagai, 2010, Obstructive sleep apnea, stroke, and cardiovascular diseases, Neurologist, 16, 329, 10.1097/NRL.0b013e3181f097cb Finkelstein, 2000, Depression in chronic dialysis patients: assessment and treatment, Nephrol Dial Transpl, 15, 1911, 10.1093/ndt/15.12.1911 Jhamb, 2009, Choices for healthy outcomes in caring for end-stage renal diseases: correlates and outcomes of fatigue among incident dialysis patients, Clin J Am Soc Nephrol, 4, 1779, 10.2215/CJN.00190109 McCann, 2000, Fatigue in persons with renal failure who require maintenance haemodialysis, J Adv Nurs, 32, 1132, 10.1046/j.1365-2648.2000.01584.x Monti, 2008, The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking, Prog Brain Res, 172, 625, 10.1016/S0079-6123(08)00929-1 Price, 1991, Neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjects, Am J Psychiatry, 148, 1518, 10.1176/ajp.148.11.1518 Schroecksnadel, 2007, Diminished quality of life in patients with cancer correlates with tryptophan degradation, J Cancer Res Clin Oncol, 133, 477, 10.1007/s00432-007-0191-3 Silber, 2010, Effects of tryptophan loading on human cognition, mood, and sleep, Neurosci Biobehav Rev, 34, 387, 10.1016/j.neubiorev.2009.08.005 Smith, 1997, Relapse of depression after rapid depletion of tryptophan, Lancet, 349, 915, 10.1016/S0140-6736(96)07044-4 Pawlak, 2002, Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure, Nephron, 90, 328, 10.1159/000049069 Saito, 1980, Tryptophan and indolic tryptophan metabolites in chronic renal failure, Am J Clin Nutr, 33, 1402, 10.1093/ajcn/33.7.1402 Handelman, 2010 Pawlak, 2001, Kynurenine and its metabolites in the rat with experimental renal insufficiency, J Physiol Pharmacol, 52, 755 Koenig, 2010, Enhanced degradation of tryptophan in patients on hemodialysis, Clin Nephrol, 74, 465, 10.5414/CNP74465 Bossola, 2015, Fatigue and plasma tryptophan levels in patients on chronic hemodialysis, Kidney Int, 88, 637, 10.1038/ki.2015.186 Haverkamp, 2016, The role of tryptophan degradation in the association between inflammatory markers and depressive symptoms in chronic dialysis patients [published online ahead of print May 24, 2016], Nephrol Dial Transpl Hays, 2005, Psychometric properties of the Medical Outcomes Study Sleep measure, Sleep Med, 6, 41, 10.1016/j.sleep.2004.07.006 Viala-Danten, 2008, Evaluation of the reliability and validity of the Medical Outcomes Study sleep scale in patients with painful diabetic peripheral neuropathy during an international clinical trial, Health Qual Life Outcomes, 6, 113, 10.1186/1477-7525-6-113 Watnick, 2005, Validation of 2 depression screening tools in dialysis patients, Am J Kidney Dis, 46, 919, 10.1053/j.ajkd.2005.08.006 Unruh, 2011, Impact of sleep quality on cardiovascular outcomes in hemodialysis patients: results from the frequent hemodialysis network study, Am J Nephrol, 33, 398, 10.1159/000326343 Allen, 2009, Psychometric evaluation and tests of validity of the Medical Outcomes Study 12-item Sleep Scale (MOS sleep), Sleep Med, 10, 531, 10.1016/j.sleep.2008.06.003 Spitzer, 1999, Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire, JAMA, 282, 1737, 10.1001/jama.282.18.1737 Kroenke, 2001, The PHQ-9: validity of a brief depression severity measure, J Gen Intern Med, 16, 606, 10.1046/j.1525-1497.2001.016009606.x DeWalt, 2007, Evaluation of item candidates: the PROMIS qualitative item review, Med Care, 45, S12, 10.1097/01.mlr.0000254567.79743.e2 Bjorner, 2007, Developing tailored instruments: item banking and computerized adaptive assessment, Qual Life Res, 16, 95, 10.1007/s11136-007-9168-6 Jhamb, 2008, Fatigue in patients receiving maintenance dialysis: a review of definitions, measures, and contributing factors, Am J Kidney Dis, 52, 353, 10.1053/j.ajkd.2008.05.005 Boers, 2010, Standing on the promises: first wave validation reports of the Patient-Reported Outcome Measurement Information System, J Clin Epidemiol, 63, 1167, 10.1016/j.jclinepi.2010.06.007 Schefold, 2009, Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms, Nephrol Dial Transpl, 24, 1901, 10.1093/ndt/gfn739 Fitzgerald, 2008, Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity, Neurogastroenterol Motil, 20, 1291, 10.1111/j.1365-2982.2008.01195.x Schroecksnadel, 2008, Quality of life and immune activation in patients with HIV-infection, Brain Behav Immun, 22, 881, 10.1016/j.bbi.2007.12.011 Viljoen, 2008, Quality of life and tryptophan levels in chronic renal failure patients on hemodialysis, Clin Nephrol, 70, 561, 10.5414/CNP70561 Huang, 2002, Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer, Br J Cancer, 86, 1691, 10.1038/sj.bjc.6600336 Bossola, 2015, Fatigue is associated with serum interleukin-6 levels and symptoms of depression in patients on chronic hemodialysis, J Pain Symptom Manage, 49, 578, 10.1016/j.jpainsymman.2014.07.009 Taraz, 2015, Association between depression and inflammatory/anti-inflammatory cytokines in chronic kidney disease and end-stage renal disease patients: a review of literature, Hemodial Int, 19, 11, 10.1111/hdi.12200 Yang, 2007, Higher plasma interleukin-18 levels associated with poor quality of sleep in peritoneal dialysis patients, Nephrol Dial Transpl, 22, 3606, 10.1093/ndt/gfm231 Jehn, 2010, Association of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancer, Integr Cancer Ther, 9, 270, 10.1177/1534735410370036 Sallee, 2014, The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease, Toxins (Basel), 6, 934, 10.3390/toxins6030934